A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement

Original Article

G.D. Dangas, J.G. Tijssen, J. Wöhrle, L. Søndergaard, M. Gilard, H. Möllmann, R.R. Makkar, H.C. Herrmann, G. Giustino, S. Baldus, O.D. Backer, A.H. Guimarães, L. Gullestad, A. Kini, D.v. Lewinski, M. Mack, R. Moreno, U. Schäfer, J. Seeger, D. Tchétché, K. Thomitzek, M. Valgimigli, P. Vranckx, R.C. Welsh, P. Wildgoose, A.A. Volkl, A. Zazula, R.G.v. Amsterdam, R. Mehran, and S. Windecker

N Engl J Med 2020;382:120-129

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
01/08/2020
Course expires: 
01/09/2022

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation

Course closed

This course closed on Sunday, January 9, 2022 - 11:59pm.